Amniotic Membrane Treatment in Routine Optometric Practice
Healing the Ocular Surface.
Course Overview
Amniotic membrane therapy has emerged as a powerful tool in the management of ocular surface disease — yet many clinicians remain uncertain about when and how to incorporate it into routine practice. This Clinical Essential provides a practical, evidence-based framework for understanding the biology of amniotic membrane, identifying appropriate clinical indications, selecting the right product for each patient, and counseling patients effectively on what to expect.
Clinical Relevance
From persistent epithelial defects to severe dry eye and post-surgical ocular surface compromise, amniotic membrane offers a regenerative option that can meaningfully change patient outcomes. Clinicians who understand the mechanism of action, available delivery formats, and clinical decision-making framework are better positioned to offer this therapy confidently and appropriately.
Course Details
Credit hours and COPE approval pending. Join the waitlist to receive notification when this course becomes available.
Learning Objectives
Upon successful completion of this educational experience, the clinician will be able to:
Describe the biological properties of amniotic membrane and the mechanisms by which it promotes ocular surface healing.
Identify appropriate clinical indications for amniotic membrane therapy in optometric practice.
Differentiate between available amniotic membrane products and delivery formats based on clinical scenario.
Apply a systematic approach to patient selection, counseling, and follow-up for amniotic membrane treatment.
Recognize contraindications and clinical scenarios in which alternative therapies may be preferred.
Course Modules
This educational experience is organized into the following modules. Content is subject to refinement prior to final release.
Biology of the Amniotic Membrane
Structure, composition, and the anti-inflammatory, anti-fibrotic, and pro-regenerative properties that make amniotic membrane a unique therapeutic tool.
Clinical Indications
Persistent epithelial defects, neurotrophic keratopathy, severe dry eye disease, chemical injuries, post-surgical ocular surface compromise, and emerging applications.
Product Landscape
Cryopreserved vs. dehydrated amniotic membrane, self-retained devices, and suture-based applications — understanding the differences and selecting appropriately.
Patient Selection and Counseling
Identifying the right patient, setting realistic expectations, and navigating insurance and access considerations in clinical practice.
Integration into Practice
Workflow considerations, follow-up protocols, and building amniotic membrane therapy into a comprehensive ocular surface disease practice.
Educational Philosophy
This educational experience is designed to support clinical reasoning and evidence-informed decision-making. It does not constitute clinical advice and should not replace consultation of official prescribing information, applicable standards of care, or the clinical judgment of the treating clinician. COPE approval and credit hours are pending and will be confirmed prior to release.
Be the First to Know
Join the waitlist for Amniotic Membrane Treatment in Routine Optometric Practice and receive notification when this educational experience becomes available.
Companion Resource
The Clinician's Companion
Explore the therapeutic reference library designed to support the clinical reasoning developed in MYODCE educational experiences.
Explore the Companion